Cargando…
Targeting the Angiopoietin/Tie Pathway: Prospects for Treatment of Retinal and Respiratory Disorders
Anti-angiogenic approaches have significantly advanced the treatment of vascular-related pathologies. The ephemeral outcome and known side effects of the current vascular endothelial growth factor (VEGF)-based anti-angiogenic treatments have intensified research on other growth factors. The angiopoi...
Autores principales: | Akwii, Racheal Grace, Mikelis, Constantinos M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479497/ https://www.ncbi.nlm.nih.gov/pubmed/34586603 http://dx.doi.org/10.1007/s40265-021-01605-y |
Ejemplares similares
-
Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology
por: Akwii, Racheal G., et al.
Publicado: (2019) -
The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma
por: Vanderborght, Bart, et al.
Publicado: (2020) -
Angiopoietin–Tie signalling in the cardiovascular and lymphatic systems
por: Eklund, Lauri, et al.
Publicado: (2016) -
The Angiopoietin-2 and TIE Pathway as a Therapeutic Target for Enhancing Antiangiogenic Therapy and Immunotherapy in Patients with Advanced Cancer
por: Leong, Alessandra, et al.
Publicado: (2020) -
Dysregulation of the angiopoietin–Tie-2 axis in sepsis and ARDS
por: Parikh, Samir M
Publicado: (2013)